Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience-Reference-Cited by-同舟云学术

Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience

Published:2019-12-03 Issue:3 Volume:98 Page:174-178
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Karachaliou Georgia Sofia,Ayvali Fatih,Collichio Frances A.,Lee Carrie B.,Ivanova Anastasia,Ollila David W.,Moschos Stergios J.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference7 articles.

1. Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017 Aug;14(8):463–82.

2. Ugurel S, Röhmel J, Ascierto PA, Flaherty KT, Grob JJ, Hauschild A, et al. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. Eur J Cancer. 2017 Sep;83:247–57.

3. Schvartsman G, Peng SA, Bis G, Lee JJ, Benveniste MF, Zhang J, et al. Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer. 2017 Oct;112:90–5.

4. Alsuwaigh R, Lee J, Chan G, Chee CE, Choo SP. Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case series. J Immunother Cancer. 2019 Jun;7(1):162.

5. Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F, et al. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity. 2016 Feb;44(2):343–54.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?;The Cancer Journal;2024-03

2. The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis;Pigment Cell & Melanoma Research;2023-12-29

3. Chemotherapie nach Progress unter Immuncheckpoint-Inhibition beim metastasierten malignen Melanom: Fallbericht und Literaturübersicht;TumorDiagnostik & Therapie;2023-11

4. Reduction-responsive dextran-based Pt(IV) nano-prodrug showed a synergistic effect with doxorubicin for effective melanoma treatment;International Journal of Biological Macromolecules;2023-04

5. Chemotherapie nach Progress unter Immuncheckpoint-Inhibition beim metastasierten malignen Melanom: Fallbericht und Literaturübersicht;Deutsche Zeitschrift für Onkologie;2023-03